Chinese artificial intelligence start-ups Moonshot AI and MiniMax have emerged as China’s strongest contenders to rival US frontier labs in 2025 – even as DeepSeek has stolen the spotlight as the ...
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...
Tech Xplore on MSN
Enabling small language models to solve complex reasoning tasks
As language models (LMs) improve at tasks like image generation, trivia questions, and simple math, you might think that ...
DeepSeek might be grabbing the headlines, but Chinese start-ups Moonshot AI and MiniMax are emerging as serious rivals to US frontier labs Chinese artificial intelligence start-ups Moonshot AI and ...
Khadija Khartit is a strategy, investment, and funding expert, and an educator of fintech and strategic finance in top universities. She has been an investor, entrepreneur, and advisor for more than ...
Genome assembly algorithms are sets of well defined procedures for reconstructing DNA sequences from large numbers of shorter DNA sequence fragments. Fragments are aligned against one another and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback